Unitary Enterprise UNITEHPROM BSU

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process	chronic venous insufficiency	Not yet recruiting	Phase 2 / Phase 3	2025-07-25	NCT06232421
An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II	Gastric Cancer With Peritoneal Dissemination	Recruiting	Phase 2 / Phase 3	2025-06-22	NCT06232434
Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis	Abdominal Adhesions	Active, not recruiting	Phase 2	2025-03-20	NCT06365632

Clinical trials